查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
亞太連續生物加工市場：按應用、最終用戶、產品和國家分類的分析和預測（2023-2033）
市場調查報告書
商品編碼
1546999

亞太連續生物加工市場：按應用、最終用戶、產品和國家分類的分析和預測（2023-2033）

Asia-Pacific Continuous Bioprocessing Market: Focus on Application, End User, Product, and Country - Analysis and Forecast, 2023-2033
出版日期: | 出版商: BIS Research | 英文 73 Pages | 商品交期: 1-5個工作天內

價格

亞太地區連續生物加工市場規模預計將從2023年的5,100萬美元成長到2033年的3.885億美元，預測期內複合年成長率為22.50%。

透過提高產量比率、靈活性、可製造性和產品一致性，同時降低製造成本來改善生物製藥製造的需求不斷成長，推動了市場的發展。為了獲得一致的結果，生物加工最近已轉向連續模式。

主要市場統計數據
預測期 2023-2033
2023年評估 5100萬美元
2033年預測 3.885 億美元
複合年成長率 22.5%

亞太地區的連續生物加工市場正在迅速擴大，在全球生物製藥領域中發揮著舉足輕重的作用。連續生物加工專注於提高生產力、適應性和產品質量，被認為是亞太地區生物製造轉型的策略。許多好處，包括提高產量、降低製造成本以及生產可靠、高品質產品的能力，使該策略成為該地區營運的生物製藥公司的理想選擇。

該地區強大的生物製藥製造基礎設施和對新型治療方法不斷成長的需求正在推動該地區廣泛採用連續上游生物加工。目前的重點是整合連續的下游生物製程、最佳化整體製程效率並進一步簡化營運。這種整合預計將改變遊戲規則，實現從開始到結束的無縫製造流程，減少停機時間，並提高生物製藥製造的可擴展性。

該地區對研發的大量投資和政府的激勵措施正在促進生物加工技術的持續發展。隨著亞太地區生物製藥市場的成長，連續生物加工的採用預計將加速，使該地區成為尖端生物製造技術的先驅。

市場分類

細分 1：依產品分類

  • 層析法系統/耗材
  • 過濾系統/設備
  • 反應器
  • 細胞培養基、細胞株、緩衝液、試劑
  • 其他

細分2：依用途

  • 單株抗體
  • 疫苗
  • 細胞/基因治療
  • 其他

細分 3：依最終使用者分類

  • 製藥和生物技術公司
  • 學術/研究機構
  • CRO

細分 4：按國家/地區分類

  • 日本
  • 印度
  • 中國
  • 韓國
  • 澳洲
  • 其他

本報告調查了亞太地區連續生物加工市場，提供了行業趨勢、技術和專利趨勢、法律制度、市場成長促進和限制因素、市場規模趨勢和預測、各個細分市場和主要領域的資訊，總結詳細的國家分析、競爭格局和主要企業概況。

目錄

執行摘要

第1章 市場

  • 趨勢：當前和未來的影響評估
    • 連續生物加工市場：趨勢分析
    • 生物製藥產業連續生物製程的數位化
    • 增加一次性生物製程設備的使用
  • 供應鏈概覽
    • 價值鏈分析
  • 研發回顧
    • 專利申請趨勢（按國家/年份）
  • 監管狀況
  • 關鍵事件影響分析：COVID-19
  • 市場動態：概述
    • 市場促進因素
    • 市場限制因素
    • 市場機會

第2章 區域

  • 區域概況
  • 亞太地區
    • 區域概況
    • 市場成長推進因素
    • 市場問題
    • 目的
    • 產品
    • 中國
    • 目的
    • 產品
    • 印度
    • 目的
    • 產品
    • 澳洲
    • 目的
    • 產品
    • 日本
    • 目的
    • 產品
    • 韓國
    • 目的
    • 產品
    • 其他
    • 目的
    • 產品

第3章市場：競爭基準化分析與公司概況

  • 下一個前沿
  • 地理評估
    • OmniBRx Biotechnologies Pvt Ltd.

第4章調查方法

Product Code: BHL2280SS

Introduction to Asia-Pacific (APAC) Continuous Bioprocessing Market

The Asia-Pacific continuous bioprocessing market was valued at $51.0 million in 2023 and is expected to reach $388.5 million by 2033, growing at a CAGR of 22.50% between 2023 and 2033. Increased demand to improve biopharmaceutical production through increased yield, flexibility, productivity, and product consistency at the same time as lower manufacturing costs is driving the APAC market for continuous bioprocessing. In order to produce consistent results, bioprocessing has been moving toward continuous mode in recent years. The goal of ongoing efforts is to integrate downstream bioprocessing into a continuous operation, thereby increasing the efficiency and capabilities of the industry, even though continuous upstream bioprocessing has been established and widely adopted.

Market Introduction

KEY MARKET STATISTICS
Forecast Period2023 - 2033
2023 Evaluation$51.0 Million
2033 Forecast$388.5 Million
CAGR22.5%

The Asia-Pacific continuous bioprocessing market is expanding quickly as the area assumes a pivotal role in the worldwide biopharmaceutical sector. As the emphasis on improving productivity, adaptability, and product quality grows, continuous bioprocessing is becoming recognized as a game-changing strategy for biomanufacturing in the Asia-Pacific region. Many benefits, such as increased yields, lower manufacturing costs, and the capacity to produce reliable, high-quality products, make this strategy a desirable one for biopharmaceutical companies operating in the area.

The region's strong biopharmaceutical manufacturing infrastructure and the rising demand for novel therapies have led to the widespread adoption of continuous upstream bioprocessing in APAC. The emphasis now is on integrating continuous downstream bioprocessing, optimizing overall process efficiency, and further streamlining operations. With seamless production flows from beginning to end, decreased downtime, and improved scalability of biopharmaceutical production, this integration is predicted to be a game-changer.

The continuous development of bioprocessing technologies is being fueled by the region's substantial investment in research and development as well as encouraging government initiatives. Continuous bioprocessing adoption is expected to pick up speed as the APAC biopharmaceutical market grows, establishing the region as a pioneer in cutting-edge biomanufacturing techniques.

Market Segmentation

Segmentation 1: by Product

  • Chromatography Systems and Consumables
  • Filtration Systems and Devices
  • Bioreactors
  • Cell Culture Media, Cell Lines, Buffers, and Reagents
  • Other Products

Segmentation 2: by Application

  • Monoclonal Antibodies
  • Vaccines
  • Cell and Gene Therapy
  • Other Applications

Segmentation 3: by End User

  • Pharmaceutical and Biotechnology Companies
  • Academic and Research Institutes
  • Contract Research Organizations

Segmentation 4: by Country

  • Japan
  • India
  • China
  • South Korea
  • Australia
  • Rest-of-Asia-Pacific

How can this report add value to an organization?

Product/Innovation Strategy: The Asia-Pacific continuous bioprocessing market has been segmented based on application, end user, and product. This can help readers get a clear overview of which segments account for the largest share and which ones are well-positioned to grow in the coming years.

Competitive Strategy: In the continuous bioprocessing market, competitive strategy centers around innovation, collaboration, customization, and sustainability. Companies in the market strive to innovate by developing more efficient, scalable, and flexible bioprocessing technologies that reduce production times and costs while maintaining high product quality. Collaboration between equipment manufacturers, biopharmaceutical companies, and research institutions is crucial for sharing knowledge, optimizing processes, and accelerating the adoption of continuous bioprocessing.

Table of Contents

Executive Summary

1 Markets

  • 1.1 Trends: Current and Future Impact Assessment
    • 1.1.1 Continuous Bioprocessing Market Trend Analysis
    • 1.1.2 Digitization of Continuous Bioprocessing by the Biopharmaceutical Industry
    • 1.1.3 Increasing Use of Single-Use or Disposable Bioprocessing Equipment
  • 1.2 Supply Chain Overview
    • 1.2.1 Value Chain Analysis
  • 1.3 Research and Development Review
    • 1.3.1 Patent Filing Trend (by Country, by Year)
  • 1.4 Regulatory Landscape
  • 1.5 Impact Analysis for Key Events: COVID-19
  • 1.6 Market Dynamics Overview
    • 1.6.1 Market Drivers
      • 1.6.1.1 Growing Demand for Continuous Bioprocessing due to the Flourishing Biopharmaceutical Sector
      • 1.6.1.2 Cost Reduction with Continuous Bioprocessing as Compared to Batch and Fed-Batch Bioprocessing
      • 1.6.1.3 Increasing Adoption of New Technologies like Single-Use Bioprocessing Technology
    • 1.6.2 Market Restraints
      • 1.6.2.1 Technological Complexities and Operational Challenges
      • 1.6.2.2 High Initial Cost Associated with Continuous Bioprocessing
    • 1.6.3 Market Opportunities
      • 1.6.3.1 Numerous Proposed Technologies in Continuous Bioprocessing
      • 1.6.3.2 Moving Closer to End-to-End Continuous Bioprocessing

2 Region

  • 2.1 Regional Summary
  • 2.2 Asia-Pacific
    • 2.2.1 Regional Overview
    • 2.2.2 Driving Factors for Market Growth
    • 2.2.3 Factors Challenging the Market
    • 2.2.4 Application
    • 2.2.5 Product
    • 2.2.6 China
    • 2.2.7 Application
    • 2.2.8 Product
    • 2.2.9 India
    • 2.2.10 Application
    • 2.2.11 Product
    • 2.2.12 Australia
    • 2.2.13 Application
    • 2.2.14 Product
    • 2.2.15 Japan
    • 2.2.16 Application
    • 2.2.17 Product
    • 2.2.18 South Korea
    • 2.2.19 Application
    • 2.2.20 Product
    • 2.2.21 Rest-of-Asia-Pacific
    • 2.2.22 Application
    • 2.2.23 Product

3 Markets - Competitive Benchmarking & Company Profiles

  • 3.1 Next Frontiers
  • 3.2 Geographic Assessment
    • 3.2.1 OmniBRx Biotechnologies Pvt Ltd.
      • 3.2.1.1 Overview
      • 3.2.1.2 Top Products/Product Portfolio
      • 3.2.1.3 Top Competitors
      • 3.2.1.4 Target Customers
      • 3.2.1.5 Key Personnel
      • 3.2.1.6 Analyst View

4 Research Methodology

  • 4.1 Data Sources
    • 4.1.1 Primary Data Sources
    • 4.1.2 Secondary Data Sources
    • 4.1.3 Data Triangulation
  • 4.2 Market Estimation and Forecast

List of Figures

  • Figure 1: Asia-Pacific Continuous Bioprocessing Market, $Million, 2023, 2026, and 2033
  • Figure 2: Asia-Pacific Continuous Bioprocessing Market (by Application), $Million, 2022, 2026, and 2033
  • Figure 3: Asia-Pacific Continuous Bioprocessing Market (by Product), $Million, 2022, 2026, and 2033
  • Figure 4: Asia-Pacific Continuous Bioprocessing Market (by End User), $Million, 2022, 2026, and 2033
  • Figure 5: Evolution of Single-Use Facilities, 2019-2022
  • Figure 6: Supply Chain and Identifying Risks within the Supply Chain
  • Figure 7: Continuous Bioprocessing Market (by Country), January 2020-December 2023
  • Figure 8: Continuous Bioprocessing Market (by Year), January 2020-December 2023
  • Figure 9: Long-Term Effect of COVID-19 on Bioprocessing, Biopharma Vs Suppliers
  • Figure 10: Impact of COVID-19 on the Continuous Bioprocessing Market, Pre, During, and Post-COVID-19 Scenario
  • Figure 11: Impact Analysis of Market Navigating Factors, 2023-2033
  • Figure 12: Growth of Biopharmaceutical Research and Development, 2012-2022, $ Million
  • Figure 13: Comparison of Processes and Facilities for Different Batch Types
  • Figure 14: Cost Comparison: Continuous vs. Batch and Fed-Batch Bioprocessing, $ Million
  • Figure 15: Respondents Using Single-Use Bioprocessing Technology, All Scales (R&D to Commercial), 2018-2022, %
  • Figure 16: Novel Bioprocessing Systems/Innovations Evaluated in 12 Months, 2021
  • Figure 17: Factors Contributing to High Initial Costs in Continuous Bioprocessing Facilities
  • Figure 18: Proposed Technologies in Continuous Biopharmaceutical Manufacturing
  • Figure 19: Developments in Continuous Bioprocessing Generating Need for End-to-End Continuous Bioprocessing Facilities
  • Figure 20: China Continuous Bioprocessing Market, $Million, 2022-2033
  • Figure 21: India Continuous Bioprocessing Market, $Million, 2022-2033
  • Figure 22: Australia Continuous Bioprocessing Market, $Million, 2022-2033
  • Figure 23: Japan Continuous Bioprocessing Market, $Million, 2022-2033
  • Figure 24: South Korea Continuous Bioprocessing Market, $Million, 2022-2033
  • Figure 25: Rest-of-Asia-Pacific Continuous Bioprocessing Market, $Million, 2022-2033
  • Figure 26: Strategic Initiatives, 2020-2023
  • Figure 27: Share of Strategic Initiatives, 2020-2023
  • Figure 28: Data Triangulation
  • Figure 29: Top-Down and Bottom-Up Approach
  • Figure 30: Assumptions and Limitations

List of Tables

  • Table 1: Market Snapshot
  • Table 2: Continuous Bioprocessing Market, Opportunities
  • Table 3: Product Portfolio Company Positioning
  • Table 4: Example of Digitization of Continuous Bioprocessing
  • Table 5: Survey on Industry Perceptions of Continuous Bioprocessing Vs Batch-Fed Processing (N=140+ Biopharmaceutical Companies)
  • Table 6: Continuous Bioprocessing Market (by Region), $Million, 2022-2033
  • Table 7: Asia-Pacific Continuous Bioprocessing Market (by Application), $Million, 2022-2033
  • Table 8: Asia-Pacific Continuous Bioprocessing Market (by End User), $Million, 2022-2033
  • Table 9: Asia-Pacific Continuous Bioprocessing Market (by Product), $Million, 2022-2033
  • Table 10: China Continuous Bioprocessing Market (by Application), $Million, 2022-2033
  • Table 11: China Continuous Bioprocessing Market (by End User), $Million, 2022-2033
  • Table 12: China Continuous Bioprocessing Market (by Product), $Million, 2022-2033
  • Table 13: India Continuous Bioprocessing Market (by Application), $Million, 2022-2033
  • Table 14: India Continuous Bioprocessing Market (by End User), $Million, 2022-2033
  • Table 15: India Continuous Bioprocessing Market (by Product), $Million, 2022-2033
  • Table 16: Australia Continuous Bioprocessing Market (by Application), $Million, 2022-2033
  • Table 17: Australia Continuous Bioprocessing Market (by End User), $Million, 2022-2033
  • Table 18: Australia Continuous Bioprocessing Market (by Product), $Million, 2022-2033
  • Table 19: Japan Continuous Bioprocessing Market (by Application), $Million, 2022-2033
  • Table 20: Japan Continuous Bioprocessing Market (by End User), $Million, 2022-2033
  • Table 21: Japan Continuous Bioprocessing Market (by Product), $Million, 2022-2033
  • Table 22: South Korea Continuous Bioprocessing Market (by Application), $Million, 2022-2033
  • Table 23: South Korea Continuous Bioprocessing Market (by End User), $Million, 2022-2033
  • Table 24: South Korea Continuous Bioprocessing Market (by Product), $Million, 2022-2033
  • Table 25: Rest-of-Asia-Pacific Continuous Bioprocessing Market (by Application), $Million, 2022-2033
  • Table 26: Rest-of-Asia-Pacific Continuous Bioprocessing Market (by End User), $Million, 2022-2033
  • Table 27: Rest-of-Asia-Pacific Continuous Bioprocessing Market (by Product), $Million, 2022-2033